DISTRIBUTION OF BETA(3)-ADRENOCEPTOR MESSENGER-RNA IN HUMAN TISSUES

被引:155
作者
BERKOWITZ, DE
NARDONE, NA
SMILEY, RM
PRICE, DT
KREUTTER, DK
FREMEAU, RT
SCHWINN, DA
机构
[1] DUKE UNIV,MED CTR,DEPT ANESTHESIOL,DURHAM,NC 27710
[2] PFIZER INC,DIV CENT RES,GROTON,CT 06340
[3] COLUMBIA UNIV,COLL PHYS & SURG,DEPT ANESTHESIOL,NEW YORK,NY 10032
[4] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[5] DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1995年 / 289卷 / 02期
关键词
BETA(3)-ADRENOCEPTOR; ADIPOSE TISSUE; GALLBLADDER; OBESITY; RNASE PROTECTION; (HUMAN);
D O I
10.1016/0922-4106(95)90098-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The beta(3)-adrenoceptor is a G protein-coupled receptor which mediates metabolic functions of the endogenous catecholamines epinephrine and norepinephrine. Questions exist regarding distribution of the beta(3)-adrenoceptor in human tissue. In order to examine the distribution of beta(3)-adrenoceptor mRNA in human tissues, we used sensitive and specific RNase protection assays without previous PCR amplification in an extensive list of human tissues. We confirm the presence of beta(3)-adrenoceptor mRNA in human white fat from several locations, gall bladder, and small intestine, as well as extend the distribution of beta(3)-adrenoceptor mRNA to previously uncharacterized human tissues such as stomach and prostate. The presence of beta(3)-adrenoceptor mRNA in human white adipose tissue has important implications regarding possible use of beta(3)-adrenoceptor selective agonists as anti-obesity agents, and the demonstration of beta(3)-adrenoceptor mRNA in a number of gastrointestinal tissues and prostate raises the question of the role of the beta(3)-adrenoceptor in motility and secretory processes.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 21 条
[1]   ATYPICAL BETA-ADRENOCEPTOR ON BROWN ADIPOCYTES AS TARGET FOR ANTI-OBESITY DRUGS [J].
ARCH, JRS ;
AINSWORTH, AT ;
CAWTHORNE, MA ;
PIERCY, V ;
SENNITT, MV ;
THODY, VE ;
WILSON, C ;
WILSON, S .
NATURE, 1984, 309 (5964) :163-165
[2]   AGONIST AND ANTAGONIST CHARACTERIZATION OF A PUTATIVE ADRENOCEPTOR WITH DISTINCT PHARMACOLOGICAL PROPERTIES FROM THE ALPHA-SUBTYPES AND BETA-SUBTYPES [J].
BOND, RA ;
CLARKE, DE .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (03) :723-734
[3]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[4]   THE HUMAN BETA-3-ADRENOCEPTOR - THE SEARCH FOR A PHYSIOLOGICAL-FUNCTION [J].
EMORINE, L ;
BLIN, N ;
STROSBERG, AD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (01) :3-7
[5]   MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
EMORINE, LJ ;
MARULLO, S ;
BRIENDSUTREN, MM ;
PATEY, G ;
TATE, K ;
DELAVIERKLUTCHKO, C ;
STROSBERG, AD .
SCIENCE, 1989, 245 (4922) :1118-1121
[6]  
ESBENSHADE TA, 1992, MOL PHARMACOL, V42, P753
[7]  
GRANNEMAN JG, 1992, MOL PHARMACOL, V42, P964
[8]  
GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895
[9]  
GRANNEMAN JG, 1993, MOL PHARMACOL, V44, P264
[10]   ANTIBODIES FOR THE IMMUNOCHEMISTRY OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
GUILLAUME, JL ;
PETITJEAN, F ;
HAASEMANN, M ;
BIANCHI, C ;
ESHDAT, Y ;
STROSBERG, AD .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02) :761-770